| Document |
Document Title |
|
WO/2024/095734A1 |
This fluorine-containing heterocyclic compound production method is for obtaining a compound represented by formula (2) through intramolecular cyclization of a compound represented by formula (1). X1 represents a hydrogen atom, a fluorin...
|
|
WO/2024/088333A1 |
The present invention relates to a metal oxygen-containing complex and a use thereof as a pre-oxidant. The metal oxygen-containing complex comprises a transition metal element as a central atom, and an oxygen-containing heterocyclic orga...
|
|
WO/2024/075082A1 |
Magnesium-infused and menthol-infused kinesiology tape is disclosed. The tape comprises an absorbent fabric substrate with adhesive on one side of the substrate to be applied to a person's skin and includes magnesium salt and menthol for...
|
|
WO/2024/071250A1 |
This diamondoid compound is a new compound represented by general formula (1) [in the formula, ring A1 represents an aliphatic ring having two or more rings, R1 represents a hydrogen atom, an alkyl group, a cycloalkyl group, or an adaman...
|
|
WO/2024/064107A1 |
Compositions include a curing agent of a fluorinated resorcinol or hydroquinone of Formula 1: R1 and R5 are independently H, halogen, optionally partially or fully halogenated C1‑18 alkyl, optionally partially or fully halogenated C1-1...
|
|
WO/2024/028516A1 |
A synthesis method for the preparation of a cannabinoid selected from cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), comprising the steps of: a) dissolving olivetol in dichloromethane (DCM) with stirring; b) adding FeCl3 * 6H2O as...
|
|
WO/2024/023360A1 |
The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-...
|
|
WO/2024/022491A1 |
Provided are a compound of Formula (I) as an FTO inhibitor with improved and selective FTO inhibition, a pharmaceutical composition comprising the same, and a method of inhibiting weight gain, promoting weight loss, reducing serum LDL, c...
|
|
WO/2024/008686A1 |
The invention relates to a method for producing 2,4,6-substituted triazines according to general formula (I) under sustainable and more eco-friendly conditions. The invention also relates to a 2,4,6-substituted triazine according to form...
|
|
WO/2024/008266A1 |
The invention relates to a method for producing 2,4,6-substituted triazines according to general formula (I) under sustainable and more eco-friendly conditions. The invention also relates to a 2,4,6-substituted triazine according to form...
|
|
WO/2023/248966A1 |
The purpose of the present invention is to newly provide a flow method that allows for continuous production from a synthesis step to a drying step by making the drying step continuous in the same manner as the synthesis step in the cont...
|
|
WO/2023/230702A1 |
Screening for novel antibacterial compounds in small molecule libraries has a low success rate. Here, we applied a machine learning (ML)-based virtual screening for antibacterial activity and evaluated its predictive power by experimenta...
|
|
WO/2023/221981A1 |
Taxamairin and analogs thereof useful in the treatment of inflammatory diseases or conditions, such as inflammatory bowel disease, pharmaceutical compositions including the same, and methods of use and preparation thereof.
|
|
WO/2023/222895A1 |
Organically bound nitrogen is removed from an ethylenically unsaturated alcohol stream by contacting the alcohol stream with a weakly acidic solid adsorbent. Trace amounts of organically bound nitrogen tend to poison the oxidation cataly...
|
|
WO/2023/219334A1 |
The present invention relates to a method for purification of a 1,4-cyclohexanedimethanol (CHDM) composition. More specifically, the present invention relates to a method for purification of CHDM, wherein the solvent water can be effecti...
|
|
WO/2023/195546A1 |
This compound is represented by formula (1): (in the formula: RG is a group that includes at least one cyclic structure; I is an iodine atom; R1 moieties may be the same as, or different from, each other, and are each a monovalent functi...
|
|
WO/2023/190598A1 |
The purpose of the present invention is to provide a composition in which additive components other than a radical generation source and a radical generation catalyst are stable for a long period of time and do not decompose readily. T...
|
|
WO/2023/155247A1 |
Provided are a single-molecular-weight amphiphilic fluorene-azobenzene oligomer, a self-assembled fiber, and a preparation method. The present invention diversifies and expands the studies of molecules having a backbone containing fluori...
|
|
WO/2023/137548A1 |
The present document describes a livestock dietary supplement composition which comprises a sialagogue comprising cinnamaldehyde, an anti-inflammatory comprising a salicylate, an expectorant comprising menthol, an antimicrobial comprisin...
|
|
WO/2023/140165A1 |
According to the present invention, a production method for a polyalcohol involves distillation refining a crude reaction liquid obtained by performing a reduction reaction on a starting material that is a polyaldehyde that has an alicyc...
|
|
WO/2023/134776A1 |
Methods for asymmetric cis-dihydroxylation ("AD") of quinones to produce cis-diols of quinones with high yield (i.e. a yield ≥ 30%) and high enantioselectivity (i.e. an enantiometric excess ≥ 30%) are disclosed. The method uses an ir...
|
|
WO/2023/132020A1 |
The present invention addresses the problem of providing: an oxygen-absorbing compound which has oxygen-absorbing properties and generates a reduced amount of odor; and an oxygen-absorbing adhesive composition and a coating agent composi...
|
|
WO/2023/104308A1 |
Suggested is the use of 4-cyclohexylbutan-2-one as a fragrance.
|
|
WO/2023/104159A1 |
The present invention relates to compounds as calcium channel blocker, a composition comprising thereof, use of said compounds and a method for treating diseases or disorders associated with calcium ion channel using said compounds. The ...
|
|
WO/2023/092076A1 |
The methods include treating cancer by the administration of an effective amount of acylfulvene to a subject in need thereof and an effective amount of radiation. The irradiation occurs before or concurrently with the administration of t...
|
|
WO/2023/056982A1 |
A herbicide compound, a preparation method therefor and an application thereof, the compound having a structure represented by formula (I), formula (II) or formula (III). The compound has a HPPD inhibitory effect, has a significant inhib...
|
|
WO/2023/015706A1 |
The present invention relates to a catalytic reaction, in particular, to a catalytic oxidation device and method. The catalytic oxidation device comprises a storage unit, a premixing unit, a microchannel reaction unit, a gas-liquid separ...
|
|
WO/2023/015709A1 |
Provided is a catalyst. Specifically, the present invention relates to a carbon-based metal-free functional quantum dot, a preparation method therefor and an application thereof. The preparation method comprises the following steps: S1: ...
|
|
WO/2023/006908A1 |
The present invention relates to the field of organic synthesis and, more specifically, it concerns a process for the preparation of an oxacylopentane or oxacylohexane derivative of formaul (II) comprising the cyclodehydration of a 1,4- ...
|
|
WO/2023/010119A1 |
A method of treating cancer includes a combination of a therapeutically effective amount of an illudin or an illudin analog thereof, derivative, or a pharmaceutically acceptable salt thereof; and a therapeutically effective amount of a P...
|
|
WO/2023/281040A1 |
The present invention relates to novel bi-functionalized trans-cyclooctenes of formula (I). It also relates to conjugates, compositions, medical uses of such compounds, and methods for producing such compounds as well as conjugates of su...
|
|
WO/2023/277347A1 |
The present invention relates to a tricyclodecane dimethanol composition in which the ratio of isomers is controlled, and a method for preparing same.
|
|
WO/2022/265240A1 |
The present invention relates to a tricyclodecane dimethanol composition in which the ratio of structural isomers is controlled, and a method for preparing same.
|
|
WO/2022/260947A1 |
Processes for converting a hydrocarbon reactant into an alcohol compound and/or a carbonyl compound are disclosed in which the hydrocarbon reactant and either a supported chromium (VI) catalyst or a supported chromium (II) catalyst are c...
|
|
WO/2022/255696A1 |
The present invention relates to: a tricyclodecane dimethanol composition which exhibits excellent solvent resistance and chemical resistance when forming a coating film, and can be suitably used for preparing a polyester resin having ex...
|
|
WO/2022/255695A1 |
The present invention relates to a tricyclodecane dimethanol composition and a preparation method therefor, wherein the composition wherein the composition has a reduced content of impurities and thus can be helpfully used in the prepara...
|
|
WO/2022/237904A1 |
A naphthalene ring-containing compound, a pharmaceutical composition containing same, and the use thereof. A naphthalene ring-containing compound as represented by formula III, a pharmaceutically acceptable salt thereof, a solvate thereo...
|
|
WO/2022/234590A1 |
The present invention discloses an industrial process for the manufacturing of Terpineol with controlled optical rotation range i.e., -12º to -14ºo. The Terpineol production process comprises of various steps including, separation of a...
|
|
WO/2022/227459A1 |
Disclosed are a polycarbonate and a synthesis method therefor, and a rigid monomer and a preparation method therefor. The polycarbonate comprises the structural unit as shown in formula (i) below; in addition, the polycarbonate can be sy...
|
|
WO/2022/224820A1 |
The present invention provides: a compound represented by formula I, formula I', formula II, or formula II'; and a composition that is for regulating circadian rhythm and that contains said compound or an Agrocybe erebia culture.
|
|
WO/2022/223117A1 |
The present invention relates to a method for preparing cis-cedrene diol, involving: providing alpha-cedrene in a solvent, which comprises or consists of water and at least one additional protic solvent; adding potassium permanganate and...
|
|
WO/2022/171652A2 |
The present invention relates to a method of hydrolysing bicyclic monoterpenes with an α/β-hydrolase-fold esterase being a carboxyl esterase comprising or consisting of an amino acid sequence with at least 80% identity to SEQ ID No. 1 ...
|
|
WO/2022/167266A1 |
The present invention provides an improved process for controlling an exothermic vapor phase hydrogenation of phenol that is catalyzed by a palladium comprising catalyst in an industrial scale hydrogenation reactor, wherein the reactor i...
|
|
WO/2022/164121A1 |
The present invention relates to a method for manufacturing a heterogeneous metal hydrogenation catalyst. More specifically, the present invention is characterized in that when the hydrogenation catalyst is reduced using a specific reduc...
|
|
WO/2022/154782A1 |
Systems and methods are provided for ozonolysis of polycyclic aromatic hydrocarbons (PAHs) in a liquid CO2 reaction environment. It has been unexpectedly discovered that oxygen- containing functional groups can be added to PAH substrates...
|
|
WO/2022/144482A1 |
The present invention relates to the synthesis and use of 12-DEOXYPHORBOL derivatives (or phorbol esters) to promote the differentiation of neurons from neural precursors or neural stem cells in culture and in the adult brain. The invent...
|
|
WO/2022/144436A1 |
The present invention refers to a process for the asymmetric synthesis of isopiperitenol and successor compounds.
|
|
WO/2022/147072A1 |
The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene...
|
|
WO/2022/138748A1 |
The present invention provides a labeling method that comprises a step for labeling a substrate, which has a carbon-hydrogen bond, with an oxygen isotope with use of a catalyst and an oxidant that is produced from a hypervalent iodine co...
|
|
WO/2022/140580A1 |
The present invention provides for xanthophyll derivatives and compositions comprising the xanthophyll derivatives as well methods of making and using the same. The compositions include pharmaceutical compositions as well as foodstuffs, ...
|
